A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Refurbishing Ventilators: A New 501(c)3 Begins Returning Tired Ventilators To Service COVID-19 Patients

The Co-Vents team of ventilator and pulmonary experts have received expedited approval from the IRS for their 501(c)3 not-for-profit designation in just 11 days after company formation.

This designation allows Co-Vents donors to receive a tax deduction for supporting our mission of returning retired ventilators to active service for COVID-19 patients. Those interested in joining this life-saving mission can donate directly here.

Co-Vents will draw upon its founders’ long history in the manufacturing of leading-edge respiratory ventilators to refurbish “retired” ventilators and quickly bring them to market to address the pandemic of respiratory illness brought on by the coronavirus. For patients whose breathing has been significantly compromised by the virus, ventilators deliver air to the lungs to help keep these patients alive.  Our average turnaround time from ventilator donation to live clinical use will be just over a week.

“Our team is energized by the donation response that we have received to our life-saving mission,” Paul Woodring, CEO and Co-Founder of Co-Vents, said. “We are focused on closing this short-term 60-day ventilator supply gap for COVID-19 patients while new ventilator production ramps up.”

The first donated and acquired ventilators have been delivered to our designated FDA and ISO approved refurbishment facilities.  Once the FDA certification is completed, Co-Vents will work with the state and federal response teams to ensure that our ventilators are delivered to patients in the areas hardest hit by the Coronavirus.

“We are grateful to our attorneys from Charitable Allies and the IRS for working together to approve our expedited 501(c)3 request in record time.  This designation allows donors to receive a tax deduction while funding this critical mission,” Co-Founder Michael Raymer said.

SourceCo-Vents
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy